RIGEL PHARMACEUTICALS

rigel-pharmaceuticals-logo

Rigel Pharmaceuticals, Inc. (Rigel), is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. The Company has product development programs in inflammatory/autoimmune diseases, such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

#People #Financial #Website #More

RIGEL PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
1996-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.rigel.com

Total Employee:
101+

Status:
Active

Contact:
650-624-1100

Email Addresses:
communications@rigel.com

Total Funding:
192.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Apache



Current Advisors List

walter-h-moos_image

Walter H. Moos Member of the Board of Directors @ Rigel Pharmaceuticals
Board_member
1997-01-01

frank-torti_image

Frank Torti Investor @ Rigel Pharmaceuticals
Board_member

Current Employees Featured

kamil-ali-jackson_image

Kamil Ali Jackson
Kamil Ali Jackson Board Member @ Rigel Pharmaceuticals
Board Member
2021-12-01

dave-santos_image

Dave Santos
Dave Santos Executive Vice President and Chief Commercial Officer @ Rigel Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2020-08-01

wolfgang-dummer_image

Wolfgang Dummer
Wolfgang Dummer Chief Medical Officer, Executive Vice President @ Rigel Pharmaceuticals
Chief Medical Officer, Executive Vice President

elliott-grossbard_image

Elliott Grossbard
Elliott Grossbard EVP & CMO @ Rigel Pharmaceuticals
EVP & CMO
2002-01-01

raul-r-rodriguez_image

Raul R. Rodriguez
Raul R. Rodriguez President & CEO @ Rigel Pharmaceuticals
President & CEO
2014-11-01

anne-marie-duliege_image

Anne-Marie Duliege
Anne-Marie Duliege Executive Vice President, Chief Medical Officer @ Rigel Pharmaceuticals
Executive Vice President, Chief Medical Officer
2016-01-01

dolly-vance_image

Dolly Vance
Dolly Vance EVP, Corporate Affairs and General Counsel @ Rigel Pharmaceuticals
EVP, Corporate Affairs and General Counsel

dean-l-schorno_image

Dean L. Schorno
Dean L. Schorno CFO @ Rigel Pharmaceuticals
CFO
2018-05-01

Founder


thomas-a-raffin_image

Thomas A. Raffin

Stock Details


Company's stock symbol is NASDAQ:RIGL

Investors List

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Rigel Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Rigel Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Post-IPO Equity - Rigel Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Rigel Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Post-IPO Equity - Rigel Pharmaceuticals

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Post-IPO Equity - Rigel Pharmaceuticals

Official Site Inspections

http://www.rigel.com Semrush global rank: 1.08 M Semrush visits lastest month: 30.65 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Rigel Pharmaceuticals"

Corporate Governance :: Rigel Pharmaceuticals, Inc. (RIGL)

Hannah began her career at Quintiles, a global contract research organization, where she specialized in overseeing early to registrational-stage oncology clinical trials. Dr. Hannah has …See details»

Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.See details»

ESG :: Rigel Pharmaceuticals, Inc. (RIGL)

Rigel is a commercial pharmaceutical company that operates without physical manufacturing facilities. We focus on innovative therapeutic advancements with a lean and agile …See details»

Governance Documents :: Rigel Pharmaceuticals, Inc. (RIGL)

Corporate Governance, Health Care Compliance Oversight, and Nominating Committee Charter Download Corporate Governance, Health Care Compliance Oversight, and Nominating …See details»

Rigel Pharmaceuticals - Crunchbase Company Profile & Funding

Organization. Rigel Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Rigel Pharmaceuticals develops …See details»

Home - Rigil

Better tech. Rigil is committed to being the best technology company that delivers meaningful solutions to our government customers. Rakhi Sharma founded Rigil in 2005 on one premise: …See details»

Rigel Provides Business Update and 2025 Outlook - PR Newswire

Jan 13, 2025 Rigel anticipates 2025 total revenue of approximately $200 to $210 ... year for Rigel as we successfully executed on our corporate strategy to grow our hematology and oncology focused organization ...See details»

Rigel - Crunchbase Company Profile & Funding

Reaping the fruits of two decades of intensive research and development, Rigel has expanded our range of flagship products and our comprehensive portfolio now includes integrated sensor …See details»

Rigel

RIGEL operates discreetly at the highest levels, making use of direct access to leaders, their advisors, key influencers, decision makers and validators. ... EBRO Global is a not for profit …See details»

Rigel Associates, LLC – Divestopedia

Nov 9, 2023 Rigel Associates is a private equity group that invests in companies with revenues exceeding $20 million, consistent histories of cash flow, demonstrated market differentiation …See details»

RIGEL ONECARE

RIGEL ONECARE is a patient support center sponsored by Rigel Pharmaceuticals, Inc. 611 Gateway Blvd., Suite 900, South San Francisco, CA 94080 The site is intended for use by …See details»

Rigel Global Inc.

Rigel is a global underwriting leader providing best-in-class property, casualty and specialty reinsurance and insurance solutions that address customers’ most pressing challenges. …See details»

Rigel – Welcome To AdvanceLiving™

Rigel's "IoT" system provides a one-stop-service essential for commercial clients' daily toilet operations and optimising capital and operation resources - we aim to enhance the customer …See details»

Rigel Provides Business Update and 2025 Outlook - Yahoo Finance

Jan 13, 2025 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today provided a business update …See details»

Management Team :: Rigel Pharmaceuticals, Inc. (RIGL)

Ms. Patel joined Rigel from IDEAYA Biosciences, Inc., where she held the role of Vice President, Human Resources, responsible for organizational planning, talent management, leadership …See details»

Rigel Pharmaceuticals (RIGL) Business Metrics & Revenue Breakdown

18 hours ago Business metrics and revenue breakdowns for Rigel Pharmaceuticals (RIGL). Includes revenue by product/segment and other key performance indicators.See details»

Home - Rigel Foundation

Rigel Foundation is a non-profit organization that works to improve the lives of people and communities around the world. We focus on areas such as education, health, environment, …See details»

Rigel – Rigel Official Website

Via Terenzio 35, 00193 Rome (Italy) Tel +39 06 688999.1 Fax +39 06 688999.23 Email: rigel.hitech@rig.itSee details»

Investor Relations :: Rigel Pharmaceuticals, Inc. (RIGL)

Mar 4, 2025 Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation. Mar 10, 2025 • 8:05am EDT Rigel Appoints Mark W. …See details»

New plans for the Rigel S.p.A. Group - Rigel

Nov 4, 2024 Rome, October 30th 2024 – Rigel S.p.A, European leader in contamination control, has presented at the Annual Strategic Meeting the strategies which will guide its global …See details»

linkstock.net © 2022. All rights reserved